CompletedPhase 1NCT04913519

A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Technoderma Medicines Inc.
Principal Investigator
Daniel Piacquadio, M.D., MD
Therapeutics Incorporated
Intervention
TDM-105795(drug)
Enrollment
30 enrolled
Eligibility
18-55 years · MALE
Timeline
20212021

Study locations (2)

Collaborators

Therapeutics, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04913519 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials